PT Kalbe Farma Tbk (PTKFF)
0.0926
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
PT Kalbe Farma Price to Book Value: 3.125 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.125 |
| May 02, 2024 | 3.037 |
| May 01, 2024 | 3.037 |
| April 30, 2024 | 3.037 |
| April 29, 2024 | 3.037 |
| April 26, 2024 | 3.037 |
| April 25, 2024 | 3.037 |
| April 24, 2024 | 3.037 |
| April 23, 2024 | 3.037 |
| April 22, 2024 | 3.037 |
| April 19, 2024 | 3.037 |
| April 18, 2024 | 3.037 |
| April 17, 2024 | 3.037 |
| April 16, 2024 | 3.037 |
| April 15, 2024 | 3.037 |
| April 12, 2024 | 3.037 |
| April 11, 2024 | 3.037 |
| April 10, 2024 | 3.037 |
| April 09, 2024 | 3.037 |
| April 08, 2024 | 3.037 |
| April 05, 2024 | 3.037 |
| April 04, 2024 | 3.037 |
| April 03, 2024 | 3.037 |
| April 02, 2024 | 3.037 |
| April 01, 2024 | 3.037 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.037 |
| March 27, 2024 | 3.037 |
| March 26, 2024 | 3.037 |
| March 25, 2024 | 3.037 |
| March 22, 2024 | 3.037 |
| March 21, 2024 | 3.037 |
| March 20, 2024 | 3.037 |
| March 19, 2024 | 3.037 |
| March 18, 2024 | 3.037 |
| March 15, 2024 | 3.037 |
| March 14, 2024 | 3.037 |
| March 13, 2024 | 3.037 |
| March 12, 2024 | 3.037 |
| March 11, 2024 | 3.037 |
| March 08, 2024 | 3.344 |
| March 07, 2024 | 3.344 |
| March 06, 2024 | 3.344 |
| March 05, 2024 | 3.344 |
| March 04, 2024 | 3.344 |
| March 01, 2024 | 3.344 |
| February 29, 2024 | 3.344 |
| February 28, 2024 | 3.344 |
| February 27, 2024 | 3.344 |
| February 26, 2024 | 3.344 |
| February 23, 2024 | 3.344 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.512
Minimum
Mar 26 2020
6.119
Maximum
Dec 30 2022
4.014
Average
3.988
Median
Mar 08 2022
Price to Book Value Benchmarks
| Taihe Group Inc | -- |
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
| NovaBay Pharmaceuticals Inc | 2.094 |
Price to Book Value Related Metrics
| PE Ratio | 23.71 |
| PS Ratio | 2.154 |
| Price | 0.0926 |
| Earnings Yield | 4.22% |
| Market Cap | 4.283B |
| Operating PE Ratio | 18.11 |
| Normalized PE Ratio | 23.84 |